GB2443318A - Phototherapeutic apparatus for treatment of body cavities - Google Patents

Phototherapeutic apparatus for treatment of body cavities Download PDF

Info

Publication number: GB2443318A
Authority: GB; United Kingdom
Prior art keywords: light; phototherapeutic apparatus; insertion member; distal end; phototherapeutic
Prior art date: 2006-10-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

GB0720738A

Other languages

English (en)

Other versions

GB0720738D0 (en

Inventor

James R Flom

Peter Louis Johnson

Jonathan Lockhart Podmore

Norbert H Leclerc

John E Crowe

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Allux Medical Inc

Original Assignee

Allux Medical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-23

Filing date

2007-10-23

Publication date

2008-04-30

2007-10-23 Application filed by Allux Medical Inc filed Critical Allux Medical Inc

2007-12-05 Publication of GB0720738D0 publication Critical patent/GB0720738D0/en

2008-04-30 Publication of GB2443318A publication Critical patent/GB2443318A/en

Status Withdrawn legal-status Critical Current

Links

238000011282 treatment Methods 0.000 title description 42
238000003780 insertion Methods 0.000 claims abstract description 144
230000037431 insertion Effects 0.000 claims abstract description 144
230000003287 optical effect Effects 0.000 claims abstract description 32
230000037361 pathway Effects 0.000 claims abstract description 12
230000001225 therapeutic effect Effects 0.000 claims description 52
239000000463 material Substances 0.000 claims description 35
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 34
229920003023 plastic Polymers 0.000 claims description 24
239000004033 plastic Substances 0.000 claims description 24
238000001126 phototherapy Methods 0.000 claims description 19
239000010453 quartz Substances 0.000 claims description 16
239000005350 fused silica glass Substances 0.000 claims description 15
239000007788 liquid Substances 0.000 claims description 14
239000002245 particle Substances 0.000 claims description 14
229920002379 silicone rubber Polymers 0.000 claims description 14
239000004945 silicone rubber Substances 0.000 claims description 14
125000006850 spacer group Chemical group 0.000 claims description 14
239000013307 optical fiber Substances 0.000 claims description 11
229920001971 elastomer Polymers 0.000 claims description 9
210000000613 ear canal Anatomy 0.000 claims description 8
239000000806 elastomer Substances 0.000 claims description 7
239000011521 glass Substances 0.000 claims description 7
229910052751 metal Inorganic materials 0.000 claims description 6
239000002184 metal Substances 0.000 claims description 6
229920001343 polytetrafluoroethylene Polymers 0.000 claims description 5
239000012530 fluid Substances 0.000 claims description 4
239000004810 polytetrafluoroethylene Substances 0.000 claims description 4
150000001875 compounds Chemical class 0.000 claims description 2
239000005060 rubber Substances 0.000 claims description 2
230000005855 radiation Effects 0.000 abstract description 42
210000001519 tissue Anatomy 0.000 description 148
239000000835 fiber Substances 0.000 description 54
238000000034 method Methods 0.000 description 37
208000037062 Polyps Diseases 0.000 description 35
208000000592 Nasal Polyps Diseases 0.000 description 27
230000001276 controlling effect Effects 0.000 description 21
238000002560 therapeutic procedure Methods 0.000 description 21
210000003928 nasal cavity Anatomy 0.000 description 18
238000001959 radiotherapy Methods 0.000 description 16
208000016366 nasal cavity polyp Diseases 0.000 description 15
230000007246 mechanism Effects 0.000 description 9
206010039085 Rhinitis allergic Diseases 0.000 description 8
201000010105 allergic rhinitis Diseases 0.000 description 8
229940079593 drug Drugs 0.000 description 8
239000003814 drug Substances 0.000 description 8
210000003979 eosinophil Anatomy 0.000 description 8
238000005286 illumination Methods 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
210000000959 ear middle Anatomy 0.000 description 7
238000003384 imaging method Methods 0.000 description 7
238000002483 medication Methods 0.000 description 7
238000001228 spectrum Methods 0.000 description 7
210000004027 cell Anatomy 0.000 description 6
238000009826 distribution Methods 0.000 description 6
210000001744 T-lymphocyte Anatomy 0.000 description 5
230000008859 change Effects 0.000 description 5
238000005253 cladding Methods 0.000 description 5
208000015181 infectious disease Diseases 0.000 description 5
210000003491 skin Anatomy 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
210000003454 tympanic membrane Anatomy 0.000 description 5
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
239000013566 allergen Substances 0.000 description 4
210000003484 anatomy Anatomy 0.000 description 4
230000006907 apoptotic process Effects 0.000 description 4
201000008937 atopic dermatitis Diseases 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
210000002850 nasal mucosa Anatomy 0.000 description 4
238000002428 photodynamic therapy Methods 0.000 description 4
230000008569 process Effects 0.000 description 4
208000012657 Atopic disease Diseases 0.000 description 3
206010012438 Dermatitis atopic Diseases 0.000 description 3
206010020751 Hypersensitivity Diseases 0.000 description 3
108010002616 Interleukin-5 Proteins 0.000 description 3
230000007815 allergy Effects 0.000 description 3
229910052782 aluminium Inorganic materials 0.000 description 3
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
229940088710 antibiotic agent Drugs 0.000 description 3
208000010668 atopic eczema Diseases 0.000 description 3
230000009286 beneficial effect Effects 0.000 description 3
239000011162 core material Substances 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
238000013461 design Methods 0.000 description 3
230000006870 function Effects 0.000 description 3
239000007789 gas Substances 0.000 description 3
208000027866 inflammatory disease Diseases 0.000 description 3
230000002757 inflammatory effect Effects 0.000 description 3
210000004877 mucosa Anatomy 0.000 description 3
210000001331 nose Anatomy 0.000 description 3
210000003800 pharynx Anatomy 0.000 description 3
206010041232 sneezing Diseases 0.000 description 3
210000001050 stape Anatomy 0.000 description 3
239000000126 substance Substances 0.000 description 3
210000001944 turbinate Anatomy 0.000 description 3
OOOQNKMJLOLMHC-UHFFFAOYSA-N 5-[[3,4-diethyl-5-[[5-formyl-3-(3-hydroxypropyl)-4-methyl-1h-pyrrol-2-yl]methyl]-1h-pyrrol-2-yl]methyl]-4-(3-hydroxypropyl)-3-methyl-1h-pyrrole-2-carbaldehyde Chemical compound N1C(CC2=C(C(C)=C(C=O)N2)CCCO)=C(CC)C(CC)=C1CC=1NC(C=O)=C(C)C=1CCCO OOOQNKMJLOLMHC-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
206010003645 Atopy Diseases 0.000 description 2
VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
102000057955 Eosinophil Cationic Human genes 0.000 description 2
101710191360 Eosinophil cationic protein Proteins 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
108090000978 Interleukin-4 Proteins 0.000 description 2
241000878128 Malleus Species 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
208000003251 Pruritus Diseases 0.000 description 2
201000004681 Psoriasis Diseases 0.000 description 2
208000036071 Rhinorrhea Diseases 0.000 description 2
206010039101 Rhinorrhoea Diseases 0.000 description 2
208000026935 allergic disease Diseases 0.000 description 2
230000000172 allergic effect Effects 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
230000001427 coherent effect Effects 0.000 description 2
208000027744 congestion Diseases 0.000 description 2
238000010276 construction Methods 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
210000000883 ear external Anatomy 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000005670 electromagnetic radiation Effects 0.000 description 2
210000000981 epithelium Anatomy 0.000 description 2
210000001035 gastrointestinal tract Anatomy 0.000 description 2
210000003630 histaminocyte Anatomy 0.000 description 2
230000003463 hyperproliferative effect Effects 0.000 description 2
210000001785 incus Anatomy 0.000 description 2
210000004969 inflammatory cell Anatomy 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
230000007803 itching Effects 0.000 description 2
210000002331 malleus Anatomy 0.000 description 2
238000005259 measurement Methods 0.000 description 2
244000005700 microbiome Species 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
239000003504 photosensitizing agent Substances 0.000 description 2
229940068196 placebo Drugs 0.000 description 2
239000000902 placebo Substances 0.000 description 2
229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
239000004417 polycarbonate Substances 0.000 description 2
229920000515 polycarbonate Polymers 0.000 description 2
239000004926 polymethyl methacrylate Substances 0.000 description 2
ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
210000001533 respiratory mucosa Anatomy 0.000 description 2
206010039083 rhinitis Diseases 0.000 description 2
201000009890 sinusitis Diseases 0.000 description 2
210000003625 skull Anatomy 0.000 description 2
239000007787 solid Substances 0.000 description 2
231100000617 superantigen Toxicity 0.000 description 2
238000011477 surgical intervention Methods 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000007704 transition Effects 0.000 description 2
238000002211 ultraviolet spectrum Methods 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
238000012800 visualization Methods 0.000 description 2
HGCGQDMQKGRJNO-UHFFFAOYSA-N xenon monochloride Chemical compound [Xe]Cl HGCGQDMQKGRJNO-UHFFFAOYSA-N 0.000 description 2
VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
208000010470 Ageusia Diseases 0.000 description 1
206010002653 Anosmia Diseases 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
206010012434 Dermatitis allergic Diseases 0.000 description 1
239000004593 Epoxy Substances 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
241000282412 Homo Species 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
208000001705 Mouth breathing Diseases 0.000 description 1
206010028748 Nasal obstruction Diseases 0.000 description 1
241000158526 Nasalis Species 0.000 description 1
206010068319 Oropharyngeal pain Diseases 0.000 description 1
206010033078 Otitis media Diseases 0.000 description 1
208000037581 Persistent Infection Diseases 0.000 description 1
201000007100 Pharyngitis Diseases 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
229920000800 acrylic rubber Polymers 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
238000011360 adjunctive therapy Methods 0.000 description 1
201000009961 allergic asthma Diseases 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
238000011203 antimicrobial therapy Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000001764 biostimulatory effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229960004436 budesonide Drugs 0.000 description 1
-1 but not limited to Substances 0.000 description 1
WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
229910001634 calcium fluoride Inorganic materials 0.000 description 1
239000004568 cement Substances 0.000 description 1
238000000701 chemical imaging Methods 0.000 description 1
230000008576 chronic process Effects 0.000 description 1
210000003477 cochlea Anatomy 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
230000006378 damage Effects 0.000 description 1
210000003027 ear inner Anatomy 0.000 description 1
238000013129 endoscopic sinus surgery Methods 0.000 description 1
238000002674 endoscopic surgery Methods 0.000 description 1
208000001780 epistaxis Diseases 0.000 description 1
230000008378 epithelial damage Effects 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
210000002388 eustachian tube Anatomy 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
208000024711 extrinsic asthma Diseases 0.000 description 1
239000002657 fibrous material Substances 0.000 description 1
229940033835 flonase Drugs 0.000 description 1
229960000676 flunisolide Drugs 0.000 description 1
229960002714 fluticasone Drugs 0.000 description 1
MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 1
WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 1
239000006260 foam Substances 0.000 description 1
230000002070 germicidal effect Effects 0.000 description 1
230000003760 hair shine Effects 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
230000028993 immune response Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
238000002329 infrared spectrum Methods 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
210000002429 large intestine Anatomy 0.000 description 1
230000003902 lesion Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
230000007108 local immune response Effects 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
ORUIBWPALBXDOA-UHFFFAOYSA-L magnesium fluoride Chemical compound [F-].[F-].[Mg+2] ORUIBWPALBXDOA-UHFFFAOYSA-L 0.000 description 1
229910001635 magnesium fluoride Inorganic materials 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
238000007726 management method Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
239000007769 metal material Substances 0.000 description 1
YUUAYBAIHCDHHD-UHFFFAOYSA-N methyl 5-aminolevulinate Chemical compound COC(=O)CCC(=O)CN YUUAYBAIHCDHHD-UHFFFAOYSA-N 0.000 description 1
229940115057 methyl 5-aminolevulinate Drugs 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
229960003085 meticillin Drugs 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
239000002991 molded plastic Substances 0.000 description 1
229960001664 mometasone Drugs 0.000 description 1
QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 description 1
WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
229940002297 nasacort Drugs 0.000 description 1
239000007922 nasal spray Substances 0.000 description 1
229940097496 nasal spray Drugs 0.000 description 1
229940003691 nasonex Drugs 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
229940124624 oral corticosteroid Drugs 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
UGFMBZYKVQSQFX-UHFFFAOYSA-N para-methoxy-n-methylamphetamine Chemical compound CNC(C)CC1=CC=C(OC)C=C1 UGFMBZYKVQSQFX-UHFFFAOYSA-N 0.000 description 1
210000003695 paranasal sinus Anatomy 0.000 description 1
230000007310 pathophysiology Effects 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
230000000886 photobiology Effects 0.000 description 1
229920000058 polyacrylate Polymers 0.000 description 1
150000004032 porphyrins Chemical class 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000004224 protection Effects 0.000 description 1
230000009979 protective mechanism Effects 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
229940072265 rhinocort Drugs 0.000 description 1
229910052594 sapphire Inorganic materials 0.000 description 1
239000010980 sapphire Substances 0.000 description 1
238000006748 scratching Methods 0.000 description 1
230000002393 scratching effect Effects 0.000 description 1
230000035807 sensation Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000004904 shortening Methods 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
238000010408 sweeping Methods 0.000 description 1
239000010409 thin film Substances 0.000 description 1
230000005944 tissue migration Effects 0.000 description 1
239000010936 titanium Substances 0.000 description 1
229910052719 titanium Inorganic materials 0.000 description 1
210000003437 trachea Anatomy 0.000 description 1
238000011277 treatment modality Methods 0.000 description 1
YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
208000001319 vasomotor rhinitis Diseases 0.000 description 1
230000001720 vestibular Effects 0.000 description 1
238000001429 visible spectrum Methods 0.000 description 1
231100000054 whole-body exposure Toxicity 0.000 description 1
IGELFKKMDLGCJO-UHFFFAOYSA-N xenon difluoride Chemical compound F[Xe]F IGELFKKMDLGCJO-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0605—Ear
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0607—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0644—Handheld applicators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0654—Lamps

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Surgery (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Medical Informatics (AREA)
Otolaryngology (AREA)
Electromagnetism (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
Radiology & Medical Imaging (AREA)
Radiation-Therapy Devices (AREA)
Surgical Instruments (AREA)

GB0720738A 2006-10-23 2007-10-23 Phototherapeutic apparatus for treatment of body cavities Withdrawn GB2443318A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US86256306P	2006-10-23	2006-10-23
US86823706P	2006-12-01	2006-12-01

Publications (2)

Publication Number	Publication Date
GB0720738D0 GB0720738D0 (en)	2007-12-05
GB2443318A true GB2443318A (en)	2008-04-30

Family

ID=38829756

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0720738A Withdrawn GB2443318A (en)	2006-10-23	2007-10-23	Phototherapeutic apparatus for treatment of body cavities

Country Status (2)

Country	Link
GB (1)	GB2443318A (fr)
WO (1)	WO2008051918A2 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012014145A1 (fr) *	2010-07-26	2012-02-02	Lumenis Ltd.	Estimation de distance entre une extrémité de fibre et un tissu utilisant une modulation d'ouverture numérique
FR2997018A1 (fr) *	2012-10-23	2014-04-25	Oreal	Dispositif et procede de traitement cosmetique par la lumiere
EP2739354A1 (fr) *	2011-08-05	2014-06-11	Denis Bouboulis	Dispositif et procédé de traitement de la rhinite allergique
EP3222314A1 (fr) *	2016-03-21	2017-09-27	Joseph Feldman	Appareil de pulvérisation nasale
WO2021178655A1 (fr) *	2020-03-04	2021-09-10	Mureva Phototherapy Inc.	Sonde de luminothérapie intrabuccale
RU222441U1 (ru) *	2023-08-07	2023-12-26	Федеральное государственное бюджетное учреждение Национальный медицинский исследовательский центр "Центральный научно-исследовательский институт стоматологии и челюстно-лицевой хирургии" Министерства здравоохранения Российской Федерации	Съемная тубус-насадка для внутриротового облучения

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8317816B2 (en)	2002-09-30	2012-11-27	Acclarent, Inc.	Balloon catheters and methods for treating paranasal sinuses
US20060004323A1 (en)	2004-04-21	2006-01-05	Exploramed Nc1, Inc.	Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US7361168B2 (en)	2004-04-21	2008-04-22	Acclarent, Inc.	Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US7419497B2 (en)	2004-04-21	2008-09-02	Acclarent, Inc.	Methods for treating ethmoid disease
US7462175B2 (en)	2004-04-21	2008-12-09	Acclarent, Inc.	Devices, systems and methods for treating disorders of the ear, nose and throat
US7803150B2 (en)	2004-04-21	2010-09-28	Acclarent, Inc.	Devices, systems and methods useable for treating sinusitis
US20190314620A1 (en)	2004-04-21	2019-10-17	Acclarent, Inc.	Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US8894614B2 (en)	2004-04-21	2014-11-25	Acclarent, Inc.	Devices, systems and methods useable for treating frontal sinusitis
US9089258B2 (en)	2004-04-21	2015-07-28	Acclarent, Inc.	Endoscopic methods and devices for transnasal procedures
US9399121B2 (en)	2004-04-21	2016-07-26	Acclarent, Inc.	Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US7410480B2 (en)	2004-04-21	2008-08-12	Acclarent, Inc.	Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US8702626B1 (en)	2004-04-21	2014-04-22	Acclarent, Inc.	Guidewires for performing image guided procedures
US8932276B1 (en)	2004-04-21	2015-01-13	Acclarent, Inc.	Shapeable guide catheters and related methods
US9554691B2 (en)	2004-04-21	2017-01-31	Acclarent, Inc.	Endoscopic methods and devices for transnasal procedures
US7559925B2 (en)	2006-09-15	2009-07-14	Acclarent Inc.	Methods and devices for facilitating visualization in a surgical environment
US7654997B2 (en)	2004-04-21	2010-02-02	Acclarent, Inc.	Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
US20070208252A1 (en)	2004-04-21	2007-09-06	Acclarent, Inc.	Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses
US9351750B2 (en)	2004-04-21	2016-05-31	Acclarent, Inc.	Devices and methods for treating maxillary sinus disease
US8764729B2 (en)	2004-04-21	2014-07-01	Acclarent, Inc.	Frontal sinus spacer
US9101384B2 (en)	2004-04-21	2015-08-11	Acclarent, Inc.	Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US8146400B2 (en)	2004-04-21	2012-04-03	Acclarent, Inc.	Endoscopic methods and devices for transnasal procedures
US20070167682A1 (en)	2004-04-21	2007-07-19	Acclarent, Inc.	Endoscopic methods and devices for transnasal procedures
US8747389B2 (en)	2004-04-21	2014-06-10	Acclarent, Inc.	Systems for treating disorders of the ear, nose and throat
US10188413B1 (en)	2004-04-21	2019-01-29	Acclarent, Inc.	Deflectable guide catheters and related methods
US20060063973A1 (en)	2004-04-21	2006-03-23	Acclarent, Inc.	Methods and apparatus for treating disorders of the ear, nose and throat
US8951225B2 (en)	2005-06-10	2015-02-10	Acclarent, Inc.	Catheters with non-removable guide members useable for treatment of sinusitis
US8114113B2 (en)	2005-09-23	2012-02-14	Acclarent, Inc.	Multi-conduit balloon catheter
US8190389B2 (en)	2006-05-17	2012-05-29	Acclarent, Inc.	Adapter for attaching electromagnetic image guidance components to a medical device
US9820688B2 (en)	2006-09-15	2017-11-21	Acclarent, Inc.	Sinus illumination lightwire device
WO2008124787A2 (fr)	2007-04-09	2008-10-16	Acclarent, Inc.	Système d'ethmoïdotomie et dispositifs espaceurs implantables capables de délivrer une substance thérapeutique pour le traitement de la sinusite paranasale
US8118757B2 (en)	2007-04-30	2012-02-21	Acclarent, Inc.	Methods and devices for ostium measurement
US8485199B2 (en)	2007-05-08	2013-07-16	Acclarent, Inc.	Methods and devices for protecting nasal turbinate during surgery
US10206821B2 (en)	2007-12-20	2019-02-19	Acclarent, Inc.	Eustachian tube dilation balloon with ventilation path
WO2010014799A1 (fr)	2008-07-30	2010-02-04	Acclarent, Inc.	Dispositifs et procédés de localisation de l’ostium d’un sinus paranasal
EP2323724A1 (fr)	2008-09-18	2011-05-25	Acclarent, Inc.	Procédés et appareil de traitement de troubles d'oto-rhino-laryngologie
US20100241155A1 (en)	2009-03-20	2010-09-23	Acclarent, Inc.	Guide system with suction
US8435290B2 (en)	2009-03-31	2013-05-07	Acclarent, Inc.	System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
US7978742B1 (en)	2010-03-24	2011-07-12	Corning Incorporated	Methods for operating diode lasers
US9155492B2 (en)	2010-09-24	2015-10-13	Acclarent, Inc.	Sinus illumination lightwire device
US9795466B2 (en) *	2012-05-30	2017-10-24	Klox Technologies Inc.	Phototherapy devices and methods
US20140228875A1 (en)	2013-02-08	2014-08-14	Nidus Medical, Llc	Surgical device with integrated visualization and cauterization
US9629684B2 (en)	2013-03-15	2017-04-25	Acclarent, Inc.	Apparatus and method for treatment of ethmoid sinusitis
US9433437B2 (en)	2013-03-15	2016-09-06	Acclarent, Inc.	Apparatus and method for treatment of ethmoid sinusitis
US20150031946A1 (en)	2013-07-24	2015-01-29	Nidus Medical, Llc	Direct vision cryosurgical probe and methods of use
US9687288B2 (en)	2013-09-30	2017-06-27	Arrinex, Inc.	Apparatus and methods for treating rhinitis
RU2566436C1 (ru) *	2014-04-24	2015-10-27	Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Амурская Государственная Медицинская Академия" Министерства Здравоохранения Российской Федерации	Способ фототерапии антиоксидантом при хроническом полипозном риносинусите
US9763743B2 (en)	2014-07-25	2017-09-19	Arrinex, Inc.	Apparatus and method for treating rhinitis
CN111701144B (zh)	2015-07-28	2023-03-21	诺欧生物有限责任公司	用于对一氧化氮的光疗调节的***和方法
US20210128935A1 (en)	2015-07-28	2021-05-06	Know Bio, Llc	Phototherapeutic light for treatment of pathogens
EP3413822B1 (fr)	2016-02-11	2023-08-30	Arrinex, Inc.	Dispositif de post-ablation de nerf nasal guidée par une image
WO2017218854A1 (fr)	2016-06-15	2017-12-21	Arrinex, Inc.	Dispositifs et procédés de traitement d'une surface latérale d'une cavité nasale
US11253312B2 (en)	2016-10-17	2022-02-22	Arrinex, Inc.	Integrated nasal nerve detector ablation-apparatus, nasal nerve locator, and methods of use
CA3061352A1 (fr)	2017-04-28	2018-11-01	Arrinex, Inc.	Systemes et procedes de localisation de vaisseaux sanguins dans le traitement de la rhinite
EP4041116A4 (fr) *	2019-10-11	2023-12-13	Dentosity, LLC	Dispositif de traitement dentaire à base de lumière amélioré
US12011611B2 (en)	2020-03-19	2024-06-18	Know Bio, Llc	Illumination devices for inducing biological effects
US11986666B2 (en)	2020-03-19	2024-05-21	Know Bio, Llc	Illumination devices for inducing biological effects
US11147984B2 (en)	2020-03-19	2021-10-19	Know Bio, Llc	Illumination devices for inducing biological effects
US11654294B2 (en)	2021-03-15	2023-05-23	Know Bio, Llc	Intranasal illumination devices
WO2024089621A1 (fr) *	2022-10-26	2024-05-02	Lumenis Be Ltd.	Systèmes et méthodes de traitement d'états parodontaux avec de la lumière

Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001049194A2 (fr) *	1999-12-30	2001-07-12	Pearl Technology Holdings, Llc	Dispositif de lifting facial
US20020009275A1 (en) *	1997-07-02	2002-01-24	Williams Jeffrey B.	Light delivery systems and applications thereof
WO2002005722A1 (fr) *	2000-07-14	2002-01-24	Cardiofocus, Inc.	Instruments pour photo-ablation cardiaque
WO2002009610A1 (fr) *	2000-07-31	2002-02-07	Epicor, Inc.	Procedes et dispositifs pour therapie d'ablation cardiaque photodynamique
WO2004026122A2 (fr) *	2000-12-29	2004-04-01	Afx Inc.	Systeme d'ablation d'un tissu dote d'un dispositif d'ablation coulissant et procede associe
US20050107853A1 (en) *	2003-10-15	2005-05-19	Yosef Krespi	Control of rhinosinusitis-related, and other microorganisms in the sino-nasal tract

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6572609B1 (en) *	1999-07-14	2003-06-03	Cardiofocus, Inc.	Phototherapeutic waveguide apparatus
HU224941B1 (en) *	2001-08-10	2006-04-28	Bgi Innovacios Kft	Phototerapy apparatus
US7201767B2 (en) *	2004-05-27	2007-04-10	Bhullar Tarseam S	Device for ultraviolet radiation treatment of body tissues

2007
- 2007-10-22 WO PCT/US2007/082112 patent/WO2008051918A2/fr active Application Filing
- 2007-10-23 GB GB0720738A patent/GB2443318A/en not_active Withdrawn

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020009275A1 (en) *	1997-07-02	2002-01-24	Williams Jeffrey B.	Light delivery systems and applications thereof
WO2001049194A2 (fr) *	1999-12-30	2001-07-12	Pearl Technology Holdings, Llc	Dispositif de lifting facial
WO2002005722A1 (fr) *	2000-07-14	2002-01-24	Cardiofocus, Inc.	Instruments pour photo-ablation cardiaque
WO2002009610A1 (fr) *	2000-07-31	2002-02-07	Epicor, Inc.	Procedes et dispositifs pour therapie d'ablation cardiaque photodynamique
WO2004026122A2 (fr) *	2000-12-29	2004-04-01	Afx Inc.	Systeme d'ablation d'un tissu dote d'un dispositif d'ablation coulissant et procede associe
US20050107853A1 (en) *	2003-10-15	2005-05-19	Yosef Krespi	Control of rhinosinusitis-related, and other microorganisms in the sino-nasal tract

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012014145A1 (fr) *	2010-07-26	2012-02-02	Lumenis Ltd.	Estimation de distance entre une extrémité de fibre et un tissu utilisant une modulation d'ouverture numérique
US9017316B2 (en)	2010-07-26	2015-04-28	Lumenis Ltd.	Distance estimation between a fiber end and a tissue using numerical aperture modulation
EP2739354A1 (fr) *	2011-08-05	2014-06-11	Denis Bouboulis	Dispositif et procédé de traitement de la rhinite allergique
EP2739354A4 (fr) *	2011-08-05	2014-12-03	Denis Bouboulis	Dispositif et procédé de traitement de la rhinite allergique
FR2997018A1 (fr) *	2012-10-23	2014-04-25	Oreal	Dispositif et procede de traitement cosmetique par la lumiere
WO2014064074A1 (fr) *	2012-10-23	2014-05-01	L'oreal	Dispositif et procédé de traitement cosmétique par la lumière
CN104736199A (zh) *	2012-10-23	2015-06-24	莱雅公司	用于经光来美容处理的装置及方法
CN104736199B (zh) *	2012-10-23	2017-09-12	莱雅公司	用于经光来美容处理的装置及方法
US10173072B2 (en)	2012-10-23	2019-01-08	L'oreal	Device and method for cosmetic treatment by light
EP3222314A1 (fr) *	2016-03-21	2017-09-27	Joseph Feldman	Appareil de pulvérisation nasale
WO2021178655A1 (fr) *	2020-03-04	2021-09-10	Mureva Phototherapy Inc.	Sonde de luminothérapie intrabuccale
RU222441U1 (ru) *	2023-08-07	2023-12-26	Федеральное государственное бюджетное учреждение Национальный медицинский исследовательский центр "Центральный научно-исследовательский институт стоматологии и челюстно-лицевой хирургии" Министерства здравоохранения Российской Федерации	Съемная тубус-насадка для внутриротового облучения

Also Published As

Publication number	Publication date
GB0720738D0 (en)	2007-12-05
WO2008051918A3 (fr)	2008-06-12
WO2008051918A2 (fr)	2008-05-02

Legal Events

Date	Code	Title	Description
2009-03-18	WAP	Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)

Publication	Publication Date	Title
GB2443318A (en)	2008-04-30	Phototherapeutic apparatus for treatment of body cavities
US8206426B2 (en)	2012-06-26	Light source and fiber optic brush for light delivery
US20070219600A1 (en)	2007-09-20	Devices and methods for targeted nasal phototherapy
US11065152B2 (en)	2021-07-20	Systems and methods for the treatment of eye conditions
US10456298B2 (en)	2019-10-29	Systems and methods for the treatment of eye conditions
EP2229980B1 (fr)	2015-08-12	Traitement de pathogènes microbiologiques dans un ongle d'orteil au moyen de lumière antimicrobienne
US8574276B2 (en)	2013-11-05	Fiber optic brush for light delivery
US7435252B2 (en)	2008-10-14	Control of microorganisms in the sino-nasal tract
US7544204B2 (en)	2009-06-09	Control of halitosis-generating and other microorganisms in the non-dental upper respiratory tract
JP7507762B2 (ja)	2024-06-28	眼の状態を治療するためのシステム及び方法
CA2595587A1 (fr)	2006-08-03	Dispositifs, systemes, kits et methodes de traitement optique et therapie appliquee a une cavite biologique
US20090143842A1 (en)	2009-06-04	Phototherapy Treatment and Device for Infections, Diseases, and Disorders
US20100222852A1 (en)	2010-09-02	Apparatus and Method for Decolonizing Microbes on the Surfaces of the Skin and In Body Cavities
US20240024694A1 (en)	2024-01-25	Intraoral phototherapy probe
WO2002013905A1 (fr)	2002-02-21	Appareil de phototherapie vu ciblee de maladies de la peau et methode afferente
US20070021640A1 (en)	2007-01-25	Method and apparatus for application of light to gums
KR102146759B1 (ko)	2020-08-24	다용도 휴대용 광치료기
WO2008076986A1 (fr)	2008-06-26	Procédés et dispositifs permettant une photothérapie contrôlable
KR20220138179A (ko)	2022-10-12	내비강 광조사 치료장치